1999
DOI: 10.1590/s0074-02761999000200017
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological Approaches to Antitrypanosomal Chemotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
24
0
5

Year Published

2003
2003
2011
2011

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(29 citation statements)
references
References 41 publications
(38 reference statements)
0
24
0
5
Order By: Relevance
“…All the complexes presented ligands 7HtpO: 4,7 dihydro-7-oxo- [1,2,4] [4, H]leucine (specific activity 35-70 Ci/mmol), obtained from the Radiochemical Center (UK). The number of parasites in all cases was 7 !…”
Section: Newly Synthesized Compounds Assayedmentioning
confidence: 99%
See 1 more Smart Citation
“…All the complexes presented ligands 7HtpO: 4,7 dihydro-7-oxo- [1,2,4] [4, H]leucine (specific activity 35-70 Ci/mmol), obtained from the Radiochemical Center (UK). The number of parasites in all cases was 7 !…”
Section: Newly Synthesized Compounds Assayedmentioning
confidence: 99%
“…Both pathologies are considered a health problem in America and Africa, respectively [1]. Currently, strategies to control American trypanosomiasis (or Chagas disease) and African sleeping sickness include the development of new drugs, as the existing ones present variable effectiveness, and the kinetoplastids have developed resistance against them [2].…”
Section: Introductionmentioning
confidence: 99%
“…Both drugs have serious side effects, including vomiting, peripheral polyneuropathy, and allergic dermopathy (De Castro 1993;Rassi and Luquetti 1992;Croft et al 1997), probably as a consequence of oxidative or reductive damage in the host tissues (Urbina and Docampo 2003). Some new drugs already in test for treating this parasitic infection may have a promising future (Stoppani 1999;Croft 1999), but the lack of selective cytotoxicity against T. cruzi makes the search for new products a priority in the medical field (Sepúlveda-Boza and Cassels 1996).…”
Section: Introductionmentioning
confidence: 99%
“…Treatment for stage 1, when the parasites are limited to the hemolymphatic system, is administration of pentamidine (T. b. gambiense) or suramin (T. b. rhodesiense). In stage 2, or central nervous system (CNS) disease, either melarsoprol (T. b. gambiense and T. b. rhodesiense) or eflornithine (T. b. gambiense) is used (14). Melarsoprol kills 5 to 10% of patients (32), and treatment failures of up to 25% have been reported (12,13).…”
mentioning
confidence: 99%